Subscribe to RSS
DOI: 10.1055/s-2008-1078573
Efficient Synthesis of Dihydrobenzofurans via a Multicomponent Coupling of Salicylaldehydes, Amines, and Alkynes
Publication History
Publication Date:
02 July 2008 (online)
Abstract
A simple and efficient synthesis of dihydrobenzofurans was developed using a multicomponent coupling of various salicylaldehydes, amines, and alkynes. The use of aliphatic alkynes containing a heteroatom is critical to the success of the reaction.
Key words
multicomponent coupling - C-H bond reactions - tandem reactions - heterocycles - catalysis
- For recent publications, see:
-
1a
Van Miert S.Van Dyck S.Schmidt TJ.Brun R.Vlietinck A.Lemiere G.Pieters L. Bioorg. Med. Chem. 2005, 13: 661 -
1b
Chu G.-H.Gu M.Cassel JA.Belanger S.Graczyk TM.DeHaven RN.Conway-James N.Koblish M.Little PJ.DeHaven-Hudkins DL.Dolle RE. Bioorg. Med. Chem. 2005, 15: 5114 -
1c
Shi GQ.Drpinski JF.Zhang Y.Santini C.Sahoo SP.Berger JP.MacNaul KL.Zhou G.Agrawal A.Alvaro R.Cai T.Hernandez M.Wright SD.Moller DE.Heck JV.Meinke PT. J. Med. Chem. 2005, 48: 5589 - 2
Jimenez MC.Miranda MA.Tormos R. J. Org. Chem. 1998, 63: 1323 - 3
Bartoli G.Bosco M.Caretti D.Dalpozzo R.Todesco PE. J. Org. Chem. 1987, 52: 4381 -
4a
Bertolini F.Crotti P.Di Bussolo V.Macchia F.Pineschi M. J. Org. Chem. 2007, 72: 7761 -
4b
Kuethe JT.Wang A.Journet M.Davies IW. J. Org. Chem. 2005, 70: 3727 - 5
Nakamura I.Yamamoto Y. Chem. Rev. 2004, 104: 2127 - 6 For a recent example, see:
Szlosek-Pinaud M.Diaz P.Martinez J.Lamaty F. Tetrahedron 2007, 63: 3340 -
7a
Tietze LF.Ila H.Bell HP. Chem. Rev. 2004, 104: 3453 -
7b
Shibasaki M.Vogl EM.Ohshima T. Adv. Synth. Catal. 2004, 346: 1533 - 8
Nguyen RV.Yao X.Li CJ. Org. Lett. 2006, 8: 2397 - For recent examples of A³-coupling, see:
-
9a
Sreedhar B.Reddy PS.Krishna CSV.Babu PV. Tetrahedron Lett. 2007, 48: 7882 -
9b
Kidwai M.Bansal V.Mishra NK.Kumar A.Mozumdar S. Synlett 2007, 1581 -
9c
Li P.Wang L. Tetrahedron 2007, 63: 5455 -
9d
Gommermann N.Knochel P. Chem. Eur. J. 2006, 12: 4380 -
9e
Wei C.Mague JT.Li CJ. Proc. Natl. Acad. Sci. U.S.A. 2004, 101: 5749 - For a review of the A³-coupling see:
-
Wei C.Li Z.Li CJ. Synlett 2004, 1472 - 10
Patil NT.Wu H.Yamamoto Y. J. Org. Chem. 2005, 70: 4531 - 11
Ukhin LY.Komissarov VN.Lendeman SV.Khrustalyov VN.Struchkov YT. Chem. Heterocycl. Compd. 2002, 38: 1174 -
12a
Yan B.Liu Y. Org. Lett. 2007, 9: 4323 -
12b
Kidwai M.Bansal V.Kumar A.Mozumdar S. Green Chem. 2007, 9: 742 -
12c
Lo VKY.Liu Y.Wong MK.Che CM. Org. Lett. 2006, 8: 1529 -
12d
Wei C.Li CJ. J. Am. Chem. Soc. 2003, 125: 9584 -
13a
Reddy KM.Babu NS.Suryanarayana I.Sai Prasad PS.Lingaiah N. Tetrahedron Lett. 2006, 47: 7563 -
13b
Yan W.Wang R.Xu Z.Xu J.Lin L.Shen Z.Zhou Y. J. Mol. Catal. A: Chem. 2006, 255: 81 -
13c
Li Z.Wei C.Chen L.Varma RS.Li CJ. Tetrahedron Lett. 2004, 45: 2443 -
13d
Wei C.Li Z.Li CJ. Org. Lett. 2003, 5: 4473 - For microwave-promoted A³-coupling, see:
-
14a
Ju Y.Li CJ.Varma RS. QSAR Comb. Sci. 2004, 23: 891 -
14b
Shi L.Tu YQ.Wang M.Zhang FM.Fan CA. Org. Lett. 2004, 6: 1001 -
15a
Harkat H.Blanc A.Weibel JM.Pale P. J. Org. Chem. 2008, 73: 1620 -
15b
Liu Y.Song F.Song Z.Liu M.Yan B. Org. Lett. 2005, 7: 5409 -
15c
Chaudhuri G.Kundu NG. J. Chem. Soc., Perkin Trans. 1 2000, 775 -
15d
Gabriele B.Salerno G.Lauria E. J. Org. Chem. 1999, 64: 7687
References and Notes
Typical Experimental Procedure for the Cu-Catalyzed Coupling of Aldehyde, Amine, and Alkyne under Microwave Irradiation In a 5 mL Biotage microwave vial, salicylaldehyde (209 µL, 2 mmol), morpholine (348 µL, 4 mmol), 2-methyl-3-butyn-2-ol (387 µL, 4 mmol), and CuI (19 mg, 0.10 mmol) were mixed. The vial was then capped and was subjected to microwave irradiation for 30 min at 130 ˚C. The crude mixture was directly isolated via column chromatography on SiO2 (gradient eluent: hexane-EtOAc = 10:1 to 1:1) to give 241 mg (44% yield) of product (Table [²] , entry 6).
17Typical Experimental Procedure for the Ag-Catalyzed Coupling of Aldehyde, Amine, and Alkyne under Normal Heating Conditions Salicylaldehyde (209 µL, 2 mmol), morpholine (348 µL, 4 mmol), 2-methyl-3-butyn-2-ol (387 µL, 4 mmol), and AgCl (14.3 mg, 0.10 mmol) were mixed in a reaction flask at 80 ˚C in a oil bath in MeCN overnight. The solvent was removed under reduced pressure, and the crude mixture was isolated via column chromatography on SiO2 (gradient eluent: hexane-EtOAc = 10:1 to 1:1) to give 220 mg (44% yield) of product (Table [²] , entry 6).
18
2-Methyl-1-(3-piperidin-1-yl-3
H
-benzofuran-2-ylidene)propan-2-ol
(Table 2, Entry 1)
IR (neat): 3419 (br), 2933, 1696,
1463, 1158 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.36
(m, 1 H), 7.24 (m, 1 H), 6.99 (m, 1 H) 5.13 (s, 1 H), 4.79 (s, 1
H), 2.58 (m, 2 H), 2.40 (m, 2 H), 1.53-1.39 (m, 12 H) ppm. ¹³C
NMR (75 MHz, CDCl3): δ = 157.7,
152.2, 129.5, 126.3, 125.4, 122.2, 113.8, 109.9, 70.6, 67.8, 49.6,
30.9, 30.8, 26.5, 24.6 ppm. MS (EI): m/z (%) = 223 [M+],
214, 189. HRMS: m/z calcd for
C17H23O2N: 273.1729; found: 273.17.
1-(3-Piperidin-1-yl-3
H
-benzofuran-2-ylidenemethyl)-cyclohexanol (Table
2, Entry 2)
IR (neat): 3419 (br), 2948, 1698, 1612,
1464, 1289 cm-¹. ¹H NMR
(400 MHz, CDCl3): δ = 7.33
(m, 1 H), 7.17 (m, 1 H), 6.91 (m, 1 H), 6.85 (m, 1 H), 5.08 (s,
1 H), 4.74 (s, 1 H), 2.53 (m, 2 H), 2.32 (m, 2 H), 1.85-1.36
(m, 16 H) ppm. ¹³C NMR (100 MHz, CDCl3): δ = 157.6,
152.9, 129.4, 126.2, 125.2, 122.1, 112.4, 109.9, 71.7, 67.8, 49.6,
30.0, 26.5, 25.8, 24.6, 23.0 ppm. MS (EI): m/z (%) = 313 [M+],
229, 214. HRMS: m/z calcd for
C20H27O2N: 313.2036; found: 313.2042.
N
-[1-Ethyl-1-(3-piperidin-1-yl-3
H
-benzofuran-2-ylidenemethyl)propyl]-4-methylbenzenesulfonamide (Table
2, Entry 3)
IR (neat): 2970, 2802, 1696, 1612, 1594,
1461, 1157, 1094 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.64
(m, 2 H), 7.25 (m, 2 H), 6.92 (m, 2 H), 6.92 (m, 4 H), 5.26 (s,
1 H), 4.53 (s, 1 H), 4.19 (s, 1 H), 2.39 (m, 1 H), 2.27 (m, 1 H),
2.19 (s, 3 H), 2.03 (m, 3 H), 1.74 (m, 3 H), 1.34 (m, 6 H), 0.84
(m, 6 H) ppm. ¹³C NMR (75 MHz, CDCl3): δ = 157.5,
153.6, 142.5, 139.9, 129.6, 129.0, 127.4, 126.0, 125.3, 122.2, 110.0,
108.0, 67.8, 62.7, 49.6, 30.3, 26.3, 24.5, 21.6, 8.4 ppm. MS (EI): m/z (%) = 454 [M+],
283, 214, 155. HRMS: m/z calcd
for C26H34O3N2S: 454.2290;
found: 454.2282.
4-(3-Piperidin-1-yl-3
H
-benzofuran-2-ylidene)butan-2-ol (Table
2, Entry 4)
IR (neat): 3382 (br), 2931, 1701, 1612,
1475, 1218, 1151 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.36
(m, 1 H), 7.20 (m, 1 H), 6.94 (m, 1 H), 6.80 (m, 1 H), 4.96 (m,
1 H), 4.78 (s, 1 H), 3.93 (sept, 1 H, J = 6.0
Hz), 2.39 (m, 6 H), 1.53-1.38 (m, 9 H) ppm. ¹³C
NMR (75 MHz, CDCl3): δ = 158.1, 154.9,
129.5, 126.4, 125.9, 121.7, 109.8, 101.7, 68.1, 67.2, 49.6, 35.4,
26.4, 24.6, 23.1 ppm. MS (EI): m/z (%) = 273 [M+],
214, 188. HRMS: m/z calcd for
C17H23O2N: 273.1729; found: 273.1723.
5-(3-Diethylamino-3
H
-benzofuran-2-ylidene)pentan-1-ol (Table 2,
Entry 5)
IR (neat): 3412 (br), 2935, 1711, 1611, 1463,
1234 cm-¹. ¹H NMR
(400 MHz, CDCl3): δ = 7.27
(m, 1 H), 7.11 (m, 1 H), 6.84 (m, 1 H), 6.74 (m, 1 H), 4.78 (t,
1 H, J = 6.4
Hz), 4.62 (s, 1 H), 3.46 (m, 2 H), 2.45-2.17 (m, 4 H),
1.56-1.26 (m, 12 H) ppm. ¹³C
NMR (75 MHz, CDCl3): δ = 158.2,
152.6, 129.4, 126.4, 125.7, 121.5, 109.5, 66.8, 61.9, 49.2, 35.3, 32.0,
29.8, 25.3, 20.1 ppm. MS (EI): m/z (%) = 287 [M+], 214,
202. HRMS: m/z calcd for C18H25O2N:
287.1872; found: 287.1875.
2-Methyl-1-(3-morpholin-4-yl-3
H
-benzofuran-2-ylidene)propan-2-ol
(Table 2, Entry 6)
IR (neat): 3419 (br), 2967, 1612,
1462, 1374, 1232, 1115 cm-¹. ¹H
NMR (400 MHz; CDCl3): δ = 7.41
(m, 1 H), 7.26 (m, 1 H), 7.01 (m, 1 H), 6.94 (m, 1 H), 5.15 (s,
1 H), 4.79 (s, 1 H), 3.66 (m, 4 H), 2.63 (m, 2 H), 2.41 (m, 2 H),
1.50 (s, 3 H), 1.48 (s, 3 H) ppm. ¹³C
NMR (75 MHz CDCl3): δ = 157.7,
151.4, 136.1, 129.9, 126.3, 122.4, 114.5, 110.1, 70.6, 67.4, 48.6,
30.8, 30.8 ppm. MS (EI): m/z (%) = 275 [M+],
216, 189, 131, 86. HRMS: m/z calcd
for C16H21O3N: 275.1521; found:
275.1519.
2-Methyl-1-(3-pyrrolidin-1-yl-3
H
-benzofuran-2-ylidene)propan-2-ol
(Table 2, Entry 7)
IR (neat): 3430 (br), 2911, 1672,
1561, 1341, 1160 cm-¹. ¹H NMR
(400 MHz, CDCl3): δ = 7.35
(m, 1 H), 7.19 (m, 1 H), 6.93 (m, 1 H), 6.87 (m, 1 H), 5.12 (s,
1 H), 4.74 (s, 1 H), 2.57 (m, 2 H), 2.36 (m, 2 H), 1.54-1.24
(m, 10 H) ppm. ¹³C NMR (75 MHz, CDCl3): δ = 157.6,
152.2, 129.5, 125.4, 122.2, 113.7, 109.9, 70.6, 67.8, 49.6, 30.9,
26.5, 24.6 ppm. MS (EI): m/z (%) = 258 [M+],
189, 131. HRMS: m/z calcd for C16H21O2N:
258.1494; found: 258.1491.
2-Methyl-1-{3-piperidin-1-yl-3
H
-naphtho[2,3-
b
]furan-2-ylidene}propan-2-ol
(Table 2, Entry 8)
IR (neat): 3581 (br), 2934, 1688,
1522, 1249, 1161 cm-¹. ¹H NMR
(400 MHz CDCl3): δ = 8.18
(m, 1 H), 7.83 (m, 1 H), 7.75 (m, 1 H), 7.52 (m, 1 H), 7.38 (m,
1 H), 2.53 (m, 4 H), 1.64-1.32 (m, 12 H) ppm. ¹³C
NMR (75 MHz, CDCl3): δ = 155.2,
151.2, 131.2, 130.8, 130.5, 128.8, 127.9, 124.0, 124.0, 117.9, 115.1,
111.4, 70.9, 68.2, 49.3, 31.2, 31.1, 26.8, 25.0 ppm. MS (EI): m/z (%) = 323 [M+],
264, 181. HRMS: m/z calcd for
C21H25O2N: 323.1885; found: 323.1879.
1-(5-Chloro-3-piperidin-1-yl-3
H
-benzofuran-2-ylidene)-2-methylpropan-2-ol
(Table 2, Entry 9)
IR (neat): 3401 (br), 2936, 1702,
1608, 1469, 1234, 1154 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.34
(s, 1 H), 7.20 (m, 1 H), 6.86 (m, 1 H), 5.14 (m, 1 H), 4.76 (s,
1 H), 2.58 (m, 2 H), 2.39 (m, 2 H), 1.54-1.46 (m, 12 H)
ppm. ¹³C NMR (75 MHz, CDCl3): δ = 156.2,
152.1, 129.5, 127.4, 126.3, 114.2, 110.9, 70.6, 69.8, 67.8, 49.6,
30.9, 26.5, 24.5 ppm. MS (EI): m/z (%) = 307 [M+],
248, 223. HRMS: m/z calcd for C17H22O2N³5Cl:
307.1339; found: 307.1344. HRMS: m/z calcd
for C17H22O2N³7Cl:
309.1312; found: 309.1312.
1-(6-Methoxy-3-piperidin-1-yl-3
H
-benzofuran-2-ylidene)-2-methylpropan-2-ol
(Table 2, Entry 10)
IR (neat): 3580 (br), 2938, 1736,
1699, 1620, 1444, 1280 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.22
(m, 1 H), 6.50 (m, 1 H), 5.09 (m, 1 H), 4.67 (s, 1 H), 3.75 (s,
3 H), 2.53 (m, 2 H), 2.31 (m, 2 H), 1.49-1.36 (m, 12 H)
ppm. ¹³C NMR (75 MHz, CDCl3): δ = 161.2,
158.9, 153.0, 126.5, 117.2, 113.8, 108.1, 96.1, 70.6, 67.4, 55.7,
49.4, 30.9, 30.8, 26.4, 24.6 ppm. MS (EI): m/z (%) = 303 [M+],
244, 219. HRMS: m/z calcd for
C18H25O3N: 303.1834; found: 303.1831.
2-(4,4-Dimethyl-1-piperidin-1-yl-pent-2-ynyl)phenol (1b)
IR (neat): 2936, 2233, 1644,
1465, 1458, 1362, 1244, 1153 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.51
(m, 1 H), 7.22 (m, 1 H), 6.87 (m, 2 H), 4.88 (s, 1 H), 2.64 (m,
4 H), 1.68 (m, 6 H), 1.39 (s, 9 H) ppm. ¹³C
NMR (75 MHz, CDCl3): δ = 158.0, 129.3,
128.6, 122.1, 110.0, 116.4, 99.1, 95.41, 71.3, 60.7, 31.6, 28.0,
26.2, 24.4 ppm. MS (EI): m/z (%) = 271 [M+],
186, 84. HRMS: m/z calcd for
C18H25ON: 271.1936; found: 271.1933.